Ron Swatzyna, PhD, LCSW
We have learned in the past eight years that there is much room for improvement in the selection of medicaiton and treatment of ADHD in children and adolescents. EEG and qEEG technologies provide indentification of neurobiomarkers and are proving to be valuable tools for experienced physiciians who know how to interpret the findings and use published research suggestions to avoid medications that are likely to make their patients worse, and consider empirical trials of research-supported medications. Read the rest of the aricle from Ron Swatzyna, Ph.D., LCSW on a pdf here.